Soligenix; Deadly Marburg Virus Outbreak Highlights the Need for MarVax™ Vaccine

(4:2)

Soligenix: Rising to the Challenges of Rare Disease Treatment

(3:16)

Soligenix, Inc - Superlative Performance in Rare Diseases

(34:41)

Soligenix's Mission in Biotech: An Interview with CEO Dr. Chris Schaber

(8:25)

Soligenix, Inc. and SGX942, Taking On Oral Mucositis (NasdaqCM: SNGX)

(2:58)

Addressing the allegations… @Strong_ASTH_1947 @MCDAK47 @LeanTheIdk447

(47)

HOW A Charged Vortex MAKES Gravity: Real Electrogavitics, REAL Psychokinetics, REAL Power of MIND!

(51:13)

Deadly Marburg virus resurfaces again

(10:1econd)

Doctor Talks HBO Chernobyl, Radiation, and Nuclear Energy

(7:50)

What we know (and don't know) about Ebola - Alex Gendler

(4:1econd)

Ross \u0026 Peter Bortel SNGX

(6:19)

Marburg Virus: Origins, Transmission, Pathophysiology, Symptoms

(12:13)

SECO \u0026 SNGX Best Stocks To Buy + Day Trading LIVE ($25,000 Challenge)

(1:53:21)

Soligenix: Developing \u0026 Commercializing Treatments for Rare Diseases with Unmet Needs

(2:6)

Soligenix; Discussing the Benefits of HyBryte™ CTCL Treatment with Michael W. Young

(13:31)

Soligenix - Filling Urgent Healthcare Needs by Targeting Unaddressed Rare Diseases

(36:54)

Interview with Dr. Rick Straube of Soligenix

(9:22)

Soligenix Targets $200M CTCL Market With SGX301

(1:51)

Soligenix - U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma

(1:48:27)

Simplifying Vaccine Accessibility: Soligenix Advances Heat Stable Vaccine Candidates

(9:22)

The SGX942 Timeline

(3:56)

Discovering Treatments for Rare Diseases | Soligenix, Inc. (NASDAQ: SNGX) - GCFF (Sep 10)

(21:9)

Soligenix hits major milestones in 2022 including FDA approval for Pediatric study Plan on HyBryte

(8:18)

NIGHT TRAIN TO NOWHERE: Ten slated for executions in U.S.

(2:45)

Soligenix CEO Chris Schaber's interview with CEO3in60 Investors Update.

(8:15)

SGX942 Phase I Data

(1:41)

Soligenix Inc. (NASDAQ: SNGX) Targets $500 Million Drug Opportunity!

(3:3)